+1,961.6%
CLS vs IVZ
+39.8%
+1,921.8%
-56.5%
Performance
Returns, benchmark comparison, and relative performance.
Performance by timeframe
Returns for 5y.
| Period | Portfolio | IVZ | Excess | Alpha |
|---|---|---|---|---|
| 1D | -0.8% | +1.6% | -2.4% | -1.8% |
| 7D | +5.6% | +1.0% | +4.6% | +4.8% |
| 30D | -22.2% | +3.4% | -25.6% | -23.6% |
| 3M | -30.5% | -10.5% | -20.1% | -25.8% |
| 6M | -34.0% | +8.2% | -42.3% | -37.0% |
| YTD | -20.0% | +13.5% | -33.5% | -27.3% |
| 1Y | -23.6% | +32.9% | -56.5% | -36.5% |
| 3Y | +743.0% | +136.6% | +606.4% | +390.3% |
| 5Y | +1,961.6% | +43.5% | +1,918.2% | +1,465.3% |
| All | +1,961.6% | +39.8% | +1,921.8% | +1,465.3% |
Cumulative growth
Daily Returns
Daily percentage return beside IVZ.
Daily Out/Under-Performance
Portfolio return minus IVZ return. Positive bars indicate outperformance.
Daily Alpha
Portfolio daily return minus β × IVZ return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.
Cumulative Out/Under-Performance
Relative wealth over 5y: compounded portfolio wealth divided by compounded IVZ wealth, less one. Both series rebase at the selected span's start.
Cumulative Alpha
Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.
Updating return analytics…
5y analysis · Full analysis span regression · 6 months rolling